When life sciences meets AI: How Graph AI is redefining global drug safety
Bessemer Venture Partners leads Graph AI’s seed round, backing the team poised to disrupt an $8 billion pharmacovigilance market
The $1.4 trillion global IT services industry is in the midst of a once-in-a-generation transformation. With AI’s ability to perform deep reasoning across large, unstructured datasets and synthesize multimodal information, many repetitive, moderate complexity tasks can now be executed better, faster, and cheaper through AI-native products — with more consistency than humans.
One domain, in particular, ripe for disruption is the $8 billion pharmacovigilance market: a critical component of global drug regulation safety. Regulatory authorities require pharmaceutical companies to continuously monitor, detect, and report adverse drug events (ADEs) throughout a drug’s lifecycle, from trials to post-market use. Historically, pharmaceutical companies have outsourced this work to large service firms that employ vast teams who manually review call-center logs, legal filings, medical literature, emails, and social-media data to identify ADEs, determine causality, and prepare regulatory submissions. This process is fragmented, reactive, and heavily human-dependent — leading to inefficiencies, compliance risk, and potential brand damage.
Graph AI is redefining this workflow through its flagship product, Graph Safety. Using context-aware AI and intelligent automation, the platform delivers a comprehensive, end-to-end pharmacovigilance solution globally. Already live with enterprise customers, Graph will automate ADE case processing, signal detection, aggregate reporting, and compliance. The result is a shift from manual, error-prone operations to AI-driven workflows that augment medical reviewers, improve accuracy, and dramatically shorten reporting cycles. Enterprise customers have reported up to 70% efficiency gains, 90% faster regulatory reporting, and substantial cost savings, all while maintaining end-to-end traceability and audit readiness globally.
At Bessemer, we believe Graph’s journey reflects a larger shift unfolding across industries, where AI transforms not only how work gets done but how impact is delivered. In the AI era, our dedication to finding and backing the top vertical software innovators who can harness this groundbreaking technology is stronger than ever.
Founders Raghavendra Parvataraju (CEO), Vijay Ponukumati (CTO), Mohan Konyala (CPO), and Ashutosh Bordekar (CFO) are industry veterans with vast experience leading global organizations, including LTI Mindtree, Infosys, ServiceNow, Google, and Cisco. We believe their rare blend of expertise in technology, outsourcing, and enterprise operations uniquely positions them to build a new class of AI-first, product-driven patient safety platform that transforms this services-driven industry. We’re excited to lead their seed round to support them in harnessing AI to make pharmaceutical drugs safer for the world.
Contributors
Nithin Kaimal
Partner & BVP India Chief Operating Officer
Nithin Kaimal is a Partner at Bessemer and Chief Operating Officer of BVP India. He invests in AI-native challengers to the IT services, BPO, and KPO incumbents, companies that sell solved outcomes in complex workflows across healthcare, BFSI, life sciences, and other verticals with significant prevalence of outsourcing. He also leads Bessemer's investing in AI-first wealth management in India. He partners with founders from pre-seed through Series B, particularly those building across the India–US corridor, and is partner to Graph AI, Aivar, dCortex, and Pluro. Alongside classic venture rounds, he has a particular appetite for incubations, management buyouts, and control deals with significant room for value creation, the playbook behind Pluro. As COO, he oversees Bessemer's India fund and provides portfolio companies with services, resources, and strategic counsel.
Prior to Bessemer, Nithin spent over a decade in private equity, including IDFC Alternatives and IndiaRF (the Piramal–Bain Capital Credit JV), where he was on the founding team. He has co-founded two ventures of his own, in investment management and social commerce, and began his career at McKinsey & Company.
Nithin is a Fellow member of the Institute of Chartered Accountants of India and holds an MBA from IIM Calcutta. Outside of work, he is a marathon runner, a competitive squash player, and a drummer, three pursuits he insists are the same discipline at different tempos
